Effects of sumatriptan injection: A Synthesis of Findings from 6 Studies

  1. Home
  2. Effects of sumatriptan injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of sumatriptan injection: A Synthesis of Findings from 6 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of sumatriptan injection: A Synthesis of Findings from 6 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Sumatriptan is a commonly used medication for migraine treatment. One study, 5 , found that a lower dose (3mg) of subcutaneous sumatriptan was preferred by 80% of patients compared to the higher dose (6mg). This preference was linked to better tolerability and a comparable efficacy. Meanwhile, another study, 3 , investigated the hemodynamic effects of sumatriptan through Doppler echocardiography. The results showed that subcutaneous sumatriptan administration did not significantly affect cardiovascular parameters in patients without pre-existing hypertension or other cardiovascular diseases. Sumatriptan's potential for abuse was assessed in 1 and found to be low. However, 4 suggested that sumatriptan might have some effects on the central nervous system. Lastly, 6 examined the acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform. The study highlighted the need for further research to fully understand the impact of sumatriptan on vascular functions.

Benefits and Risks

Benefit Summary

Sumatriptan has been shown to be effective in treating migraine headaches. It is generally considered safe for individuals without pre-existing cardiovascular conditions. A lower dose of sumatriptan may be preferred by some patients, offering better tolerability without compromising efficacy.

Risk Summary

Sumatriptan can have some effects on the central nervous system, and further research is needed to fully understand its impact on blood pressure, stiffness, and vascular functions.

Comparison of Studies

Similarities

These studies demonstrate the effectiveness of sumatriptan in treating migraine headaches. They also highlight the generally safe cardiovascular profile of sumatriptan for patients without pre-existing heart conditions.

Differences

These studies vary in their dosage regimens, patient populations, and the specific parameters they evaluated. The studies also employed different methodologies.

Consistency and Discrepancies in Findings

The findings highlight the potential for sumatriptan to be effective in migraine treatment and safe for cardiovascular health. However, the studies also suggest a potential for central nervous system effects and a need for further investigation on the impact of sumatriptan on blood pressure, stiffness, and vascular functions.

Real-World Implications and Considerations

Sumatriptan can be a valuable treatment option for migraine headaches, but it is crucial for individuals to consult with their doctor to determine the most appropriate dosage, administration method, and potential risks. It is also important for patients to disclose any pre-existing medical conditions, especially heart conditions, to their healthcare provider before starting sumatriptan therapy.

Limitations of Current Research

The studies presented have limitations. Some studies focused on specific patient populations, which may not be representative of the broader population. Additionally, the long-term effects of sumatriptan remain to be fully evaluated.

Future Research Directions

Further research is necessary to investigate the long-term effects of sumatriptan on different patient populations and to determine the optimal dosage regimens and administration methods. Further research is also needed to clarify the impact of sumatriptan on cardiovascular functions and any potential central nervous system effects.

Conclusion

Sumatriptan appears to be a promising treatment for migraine headaches. However, it is essential to consult with a healthcare professional to determine the appropriate dosage and potential risks. Further research is ongoing to better understand the long-term effects and optimize the use of sumatriptan for migraine treatment.

Literature analysis of 6 papers
Positive Content
4
Neutral Content
1
Negative Content
1
Article Type
6
0
0
0
6
1.

Psychoactivity and abuse potential of sumatriptan.

Author: SullivanJ T, PrestonK L, TestaM P, BuschM, JasinskiD R

Cluster headache treatment
Migraine treatment
Psychoactive effects

Sumatriptan is a migraine and cluster headache treatment that has low abuse potential. In a study, sumatriptan showed psychoactive effects but did not produce euphoria or act as a prototypic drug of abuse.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

2.

The safety and tolerability of sumatriptan: an overview.

Author: BrownE G, EndersbyC A, SmithR N, TalbotJ C

Effective for migraines
Well tolerated
Injection pain
Unpleasant taste

Sumatriptan, a drug for migraine treatment, was generally well-tolerated in a large pool of patients. The most common side effects were unpleasant taste or pain on injection.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Succinate sumatriptan evaluation by Doppler echocardiography in patients with migraine.

Author: PaternaS, Di PasqualeP, ParrinelloG, AmatoP, BuccaV, CecalaM, CardinaleA, ManiscalchiT, TuttolomondoA, BovaA, ArrostutoA, FolloneG, BolognaP, PiovanaG, LicataG

Safe for patients without hypertension

Sumatriptan, a drug used to treat migraines, was found to be safe and well tolerated in patients without hypertension or other cardiovascular disease.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

4.

CNS effects of sumatriptan and rizatriptan in healthy female volunteers.

Author: van der PostJ, SchramM T, SchoemakerR C, PietersM S M, FuseauE, PereiraA, BaggenS, CohenA F, van GervenJ M A

Sedation

Sumatriptan and rizatriptan are migraine medications that have a sedative effect. The study found that these drugs decreased saccadic peak velocity and increased body sway, similar to temazepam, but also decreased reaction times and increased EEG alpha power. This suggests that sumatriptan and rizatriptan may have a stimulating effect on the central nervous system.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.

Author: LandyStephen H, McGinnisJudy E, McDonaldSusan A

Improved migraine tolerability
Reduced migraine frequency
Reduced migraine pain
Side effects

A lower dose of subcutaneous sumatriptan (3 mg) was preferred by 80% of patients compared to the standard dose (6 mg) for treatment of migraine attacks.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

6.

Acute effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform.

Author: VanmolkotFloris H M, de HoonJan N J M

RPE tears

Sumatriptan, a 5-hydroxytryptamine (HT)(1B/1D) receptor agonist, is effective for acute migraines but contraindicated in high-risk cardiovascular patients due to its vasoconstrictor activity. The study investigated the effects of sumatriptan on aortic blood pressure, stiffness, and pressure waveform.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.